Acupuncture needles may boost immunotherapy in tough lung cancer cases
NCT ID NCT07239661
First seen Nov 20, 2025 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study tests whether adding electroacupuncture (a type of acupuncture with mild electric pulses) to standard immunotherapy can help people with advanced non-small cell lung cancer who are too weak for aggressive treatment. About 120 participants will receive either real or sham electroacupuncture alongside their PD-1 inhibitor drugs. Researchers will track how long they live without the cancer getting worse, their quality of life, and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
RECRUITINGTianjin, Tianjin Municipality, 300193, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
electroacupuncture
What this could lead to
If it works, this could show that adding electroacupuncture to immunotherapy helps people with advanced lung cancer live longer and feel better.
What could go wrong
This is an early-stage trial with no phase designation, so results are uncertain. The sham control group may also show benefits, and the small sample size limits general conclusions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.